Evidence map›Paper›PMID 31449780›Full record

ArticleHematology/oncology and stem cell therapy2020

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.

Marcelo C Pasquini, Alok Srivastava, Syed Osman Ahmed, Mahmoud Aljurf, Yoshiko Atsuta, Carol Doleysh, Sebastian Galeano, Eliane Gluckman, Hildegard Greinix, Gregory Hale and 12 more

Abstract read
In one paragraph

Article in Hematology/oncology and stem cell therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Increasing access to allogeneic hematopoietic cell transplant: an international perspective.Hematology. American Society of Hematology. Education Program · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Marcelo C PasquiniMedical College of Wisconsin, Milwaukee, WI, USA. Electronic address: mpasquini@mcw.edu.
Alok SrivastavaDepartment of Hematology, Christian Medical College, Vellore, India.
Syed Osman AhmedOncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Mahmoud AljurfOncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation (JDCHCT), Nagoya, Japan.
Carol DoleyshMedical College of Wisconsin, Milwaukee, WI, USA.
Sebastian GaleanoUnidad de Hematología - Hospital Británico, Montevideo, Uruguay.
Eliane GluckmanHôpital Saint-Louis, Paris, France.
Hildegard GreinixMedical University of Graz, Graz, Austria.
Gregory HaleJohns Hopkins All Children's Hospital, St. Petersburg, FL, USA.
Parameswaran HariMedical College of Wisconsin, Milwaukee, WI, USA.
Shahrukh K HashmiOncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Naynesh KamaniAABB, Bethesda, MD, USA.
Mary J LaughlinCleveland Cord Blood Center, Cleveland, OH, USA.
Dietger NiederwieserUniversity of Leipzig, Leipzig, Germany.
Adriana SeberHospital Samaritano, São Paolo, Brazil.
Jeffrey SzerThe Royal Melbourne Hospital, Melbourne, Australia.
John A SnowdenJAS Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Koen Van BiesenWeill Cornell Medical College, New York, NY, USA.
Paula WatryMedical College of Wisconsin, Milwaukee, WI, USA.
Daniel J WeisdorfUniversity of Minnesota, Minneapolis, MN, USA.
Jane ApperleyHaematology Department, Imperial College, Hammersmith Hospital, London, UK.

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
NCI NIH HHS U24 CA076518
6 · The paper itself

Abstract

Hematopoietic cell transplantation (HCT) is a highly complex procedure that requires a dedicated multidisciplinary team to optimize its safety. In addition, institutions may have different needs regarding indications based on regional disease prevalence or may have an interest in developing specialized services. Yet, structured recommendations are not commonly available. Here, the Transplant Center and Recipient Issues Standing Committee for the Worldwide Network for Blood and Marrow Transplantation (WBMT) organized a structured review of all pertinent elements to establish a transplant program. First, we solicited components from committee members and grouped them in domains (infrastructure, staff, cell processing laboratory, blood banking, laboratory, radiology, pharmacy, HLA testing, ancillary services and quality). Subsequently, reviewers scored all elements on a 7-point scale, from an absolute requirement (score of 1) to not required (score of 7). An independent group of five experienced transplant physicians reviewed the rankings. Minimum requirements to establish any HCT program were identified among elements with mean score of ≤2.0, and specific elements for allogeneic and autologous HCT were identified. Mean scores >2.0-4.0 were classified as preferred recommendation, and mean scores of >4.0 to ≤7.0 were considered ideal recommendations for advanced and complex types of transplantation. This structured set of recommendations guides the prioritization of minimum requirements to establish a transplant program and to set the path for expansion and further development.

Indexed as

Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousHumansPractice Guidelines as TopicAutologous vs. allogeneic transplantsTransplant program requirements

Identifiers

PMID31449780
PMCPMC7125509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.